Active pharmaceutical ingredients suspected of contributing to antimicrobial resistance
Measurement answer
What this metric measures
Reports the weight of active pharmaceutical ingredients manufactured or used that are suspected of contributing to antimicrobial resistance, disaggregated by ingredient type and applicable value-chain stage.
Specification
Metric specification
- Result format
- Structured table
- Unit
- tonnes — source-defined reporting unit
- Reporting basis
- Reporting period covered by the organization’s disclosure
- Aggregation
- Sum of the weight of active pharmaceutical ingredients manufactured or used, reported separately by ingredient type.
- Pillar
- Environmental
- Topic
- Pollution
- Controlled domain
- Pollution
- Entity type
- Metric
Reporting boundary
Active pharmaceutical ingredients manufactured or used across direct operations, downstream and end-of-life stages.
Verified source occurrences
Framework coverage
This is one canonical metric. The bindings below show every verified framework occurrence without creating duplicate metric pages. Edition, disclosure, role, and relationship remain source-specific.
- Adopting DisclosureSource evidence
TNFD sector guidance
- Publisher
- Taskforce on Nature-related Financial Disclosures
- Edition
- Final English sector guidance collection through August 2026 (17 documents)
- Requirement
- Not Specified
- Relationship
- Defines Disclosure
- Mapping outcome
- Direct Evidence
- Source locator
- Additional sector guidance – Biotechnology and pharmaceuticals, Version 1.0 (June 2024), p. 56, Table, Impact driver / Pollution-pollution removal
- Adopting DisclosureBP.C2.3
TNFD sector guidance
- Publisher
- Taskforce on Nature-related Financial Disclosures
- Edition
- Version 1.0, June 2024
- Requirement
- Conditional
- Relationship
- Maps Source Identity
- Mapping outcome
- Published
- Source locator
- Additional sector guidance – Biotechnology and pharmaceuticals, Version 1.0 (June 2024), p. 56, Table, Impact driver / Pollution-pollution removal
Value structure
Dimensions and units
- Unit
- tonnes — source-defined reporting unit
- Reporting basis
- Reporting period covered by the organization’s disclosure
Unit meaning: Values use tonnes under the disclosed TNFD sector-guidance method, reporting period and boundary.
Table fields and units
- Active pharmaceutical ingredient type
- Value-chain stage
- Weight of active pharmaceutical ingredient suspected of contributing to antimicrobial resistance (tonnes)
Published dimensions
- Active pharmaceutical ingredient type
- Suspected contribution to antimicrobial resistance
- Value-chain stage: direct operations, downstream or end-of-life
Calculation method
Formula information
- Status
- Specified
- Formula type
- Sum
Formula
For each active pharmaceutical ingredient type, report the summed weight of active pharmaceutical ingredients manufactured or used that are suspected of contributing to antimicrobial resistance.Apply the source-defined TNFD sector-guidance method within the stated reporting boundary. This is a standalone, quantitatively reportable pollution-impact-driver metric with an explicit unit, population, value-chain applicability and required ingredient-type disaggregation. It is not equivalent to the shortlisted food-ingredient metrics, which concern sourcing, certification or management disclosures rather than pharmaceutical ingredients and antimicrobial-resistance risk.
Variables
| Symbol | Variable | Definition | Unit |
|---|---|---|---|
W_i | Weight of active pharmaceutical ingredient i | Weight of active pharmaceutical ingredient type i manufactured or used and identified as suspected of contributing to antimicrobial resistance. | tonnes |
Verified sources
Evidence and status sources
Sustopedia checked each record-specific claim directly against primary publisher material. Labels distinguish current measurement authority from future compatibility and corroborative, legal, edition, or method status context. Corroborative evidence can support a stated limitation but cannot establish the core measurement by itself.
Measurement evidence
- Measurement evidenceChecked 30 August 2026
TNFD additional sector guidance collection
- Publisher
- Taskforce on Nature-related Financial Disclosures
- Edition
- Final English sector guidance collection through August 2026 (17 documents)
- Locator
- Additional sector guidance – Biotechnology and pharmaceuticals, Version 1.0 (June 2024), p. 56, Table, Impact driver / Pollution-pollution removal
Supports: The official TNFD sector guidance supports the identity, boundary and method basis of “Active pharmaceutical ingredients suspected of contributing to antimicrobial resistance”.
Open official source
Use with context
Interpretation boundaries
Method disclosures required
Source-edition basis: TNFD sector guidance, Final English sector guidance collection through August 2026 (17 documents).
- Disclose the basis and definitions used to determine whether an active pharmaceutical ingredient is suspected of contributing to antimicrobial resistance.
- Disclose whether each reported quantity relates to manufacture, use, or another applicable value-chain stage.
- Disaggregate reported weight by active pharmaceutical ingredient type.
Record-specific limitations
- The metric covers active pharmaceutical ingredients suspected of contributing to antimicrobial resistance; it does not establish causality or quantify actual antimicrobial-resistance outcomes.
- Identification of relevant ingredients depends on application of the referenced AMR Alliance and World Health Organization definitions.
Interpret this metric with the stated reporting boundary, period convention, value shape, and unit. Results prepared with different boundaries or conventions may not be directly comparable.
Measurement evidence supports the core record-specific claims described above. Corroborative evidence can support limitations, while compatibility and status sources provide their separately labelled context. None of these cards by itself determines an organisation's legal applicability, filing readiness, assurance status, or compliance conclusion.